Domesco Medical Import - Export Joint-Stock Corporation (DMC) Fair Value & Analysis

Healthcare · VN · Market cap 2.0T VND

A solid business, screening 64% undervalued on our models.

What matters now

• Solid quality (65/100) at a price below fair value, the discount is the argument here, not the business quality.
• A fairly wide model range (57,493 VND to 121,401 VND) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.

How to read this chart

60‑month range 37,232 VND – 83,000 VND · fair‑value band 57,493 VND – 121,401 VND · the 58,000 VND price screens below the 95,266 VND fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Domesco Medical Import - Export Joint-Stock Corporation (DMC) currently trades at 58,000 VND, while our model-based Fair Value estimate is 95,266 VND, implying the stock looks roughly 64.3% undervalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Domesco Medical Import - Export Joint-Stock Corporation generated revenue of 2.1T VND at a net margin of 9.7%. Revenue grew 10.8% year over year. It earns a return on equity of 12.0%. The stock trades on a trailing P/E of 12.0. Fundamentals as of Jul 16, 2026

Our scenario range runs from 57,493 VND (bear case) to 121,401 VND (bull case); at 58,000 VND, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 64%, DMC screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples (97,121 VND) versus Asset-Based (32,571 VND). Highest evidence: Residual Income (76).

Key figures & financial health

Quality Score breakdown

About the company

Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam.

Full company description

Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthetic drug products such as, cardiovascular agents; antidiabetics; antibiotics; analgesics and antipyretic drugs; respiratory agents; gastrointestinal drugs; minerals and vitamins; and other synthetic drug products. The company offers its products under the Domesco brand name. The company was founded in 1989 and is headquartered in Cao Lãnh, Vietnam. Domesco Medical Import - Export Joint-Stock Corporation is a subsidiary of Abbott Laboratories(Chile) Holdco SpA.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Domesco Medical Import - Export Joint-Stock Corporation reported revenue of 2.1T VND in FY2025 versus 1.5T VND in FY2021, a compound +8.4%/yr. Reported net income was 198B VND in FY2025, compounding +5.6%/yr from FY2021.

Watch DMC: get an alert when its fair value changes →

Peer Group

Drug Manufacturers - Specialty & Generic · 626 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Insider activity: 30/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.